PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 185 filers reported holding PROVENTION BIO INC in Q1 2023. The put-call ratio across all filers is 1.57 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $6,097 | +245.4% | 253 | +51.5% | 0.00% | – |
| Q4 2022 | $1,765 | -85.3% | 167 | -94.4% | 0.00% | – |
| Q2 2022 | $12,000 | -53.8% | 3,000 | -14.8% | 0.00% | – |
| Q1 2022 | $26,000 | +30.0% | 3,521 | 0.0% | 0.00% | – |
| Q4 2021 | $20,000 | -51.2% | 3,521 | -45.4% | 0.00% | – |
| Q3 2021 | $41,000 | -22.6% | 6,452 | +3.4% | 0.00% | – |
| Q2 2021 | $53,000 | +1.9% | 6,239 | +24.8% | 0.00% | – |
| Q1 2021 | $52,000 | +2.0% | 5,000 | +66.7% | 0.00% | – |
| Q4 2020 | $51,000 | +34.2% | 3,000 | 0.0% | 0.00% | – |
| Q3 2020 | $38,000 | -9.5% | 3,000 | 0.0% | 0.00% | – |
| Q2 2020 | $42,000 | +50.0% | 3,000 | 0.0% | 0.00% | – |
| Q1 2020 | $28,000 | -37.8% | 3,000 | 0.0% | 0.00% | – |
| Q4 2019 | $45,000 | +125.0% | 3,000 | 0.0% | 0.00% | – |
| Q3 2019 | $20,000 | -44.4% | 3,000 | 0.0% | 0.00% | – |
| Q2 2019 | $36,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN JESS S & CO INC | 217,050 | $2,278,000 | 1.60% |
| Perceptive Advisors | 2,852,058 | $29,932,000 | 0.38% |
| 683 Capital Management, LLC | 630,000 | $6,612,000 | 0.35% |
| ADVISORY RESEARCH INC | 237,500 | $2,493,000 | 0.18% |
| GILDER GAGNON HOWE & CO LLC | 3,109,874 | $32,638,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 247,195 | $2,594,000 | 0.08% |
| Virtus ETF Advisers LLC | 16,158 | $170,000 | 0.07% |
| Walleye Capital LLC | 103,823 | $1,090,000 | 0.06% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 22,755 | $239,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 29,384 | $308,000 | 0.05% |